Skip to main content
. 2017 Jun 19;8(66):109915–109923. doi: 10.18632/oncotarget.18565

Figure 5.

Figure 5

(A) Low expression of ASNS gene correlated with ASNS promoter methylation (in ALL cells) or -7 (in AML cells). Cell lines with -7 or methylation of ASNS promoter (●) have lower ASNS expression than cell lines without these genetic aberrations (■). (B) Cell lines with -7 or methylation of ASNS promoter (●) displayed higher sensitivity to L-Asp treatment than other cell lines without these genetic aberrations (■).